156 related articles for article (PubMed ID: 15326250)
1. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
Gorson KC; Amato AA; Ropper AH
Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.
Radziwill AJ; Schweikert K; Kuntzer T; Fuhr P; Steck AJ
Eur Neurol; 2006; 56(1):37-8. PubMed ID: 16914929
[No Abstract] [Full Text] [Related]
4. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.
Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG
BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil and neurological diseases.
Vermersch P; Stojkovic T; de Seze J
Lupus; 2005; 14 Suppl 1():s42-5. PubMed ID: 15803931
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.
Benedetti L; Grandis M; Nobbio L; Beronio A; Ghiglione E; Manzino M; Primavera A; Mancardi G; Schenone A
Muscle Nerve; 2004 May; 29(5):748-9. PubMed ID: 15116381
[No Abstract] [Full Text] [Related]
8. Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy.
Bedi G; Brown A; Tong T; Sharma KR
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):634-6. PubMed ID: 20176598
[TBL] [Abstract][Full Text] [Related]
9. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kuntzer T
Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
11. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.
Stojanovic VD; Doronjski AR; Spasojevic SD; Pavlovic VS; Nikolic MM; Kovacevic BB
J Child Neurol; 2009 Aug; 24(8):997-1000. PubMed ID: 19240045
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic inflammatory demyelinating polyneuropathy.
Kleyman I; Brannagan TH
Curr Neurol Neurosci Rep; 2015 Jul; 15(7):47. PubMed ID: 26008811
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
[TBL] [Abstract][Full Text] [Related]
17. Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.
Martinez-Thompson JM; Snyder MR; Ettore M; McKeon A; Pittock SJ; Roforth MM; Mandrekar J; Mauermann ML; Taylor BV; Dyck PJB; Windebank AJ; Klein CJ
Muscle Nerve; 2018 Jun; 57(6):1000-1005. PubMed ID: 29272035
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
[TBL] [Abstract][Full Text] [Related]
19. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate in treatment-resistant inflammatory neuropathies.
Umapathi T; Hughes R
Eur J Neurol; 2002 Nov; 9(6):683-5. PubMed ID: 12453086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
